Statements September 22, 2026
IMC’s open letter to Quebec party leaders
Dear Quebec party leaders, What if we told you about a sector in Quebec that: You’d probably want to make it a priority. Attract it. Grow […]
All news
Stay informed with the latest press releases, industry updates, and insights from Innovative Medicines Canada.
Filter by
Press releases September 03, 2026
New data confirms innovative pharmaceutical industry is a major economic engine for Canada
Ottawa, September 3, 2026 – Innovative Medicines Canada (IMC) welcomes Deloitte Canada’s report showing the innovative pharmaceutical industry is a strategically important sector for Canada’s economic growth and productivity. According to […]
Press releases July 24, 2026
Federal task force report marks important step for Canada’s life sciences sector
Ottawa, July 24, 2026 – Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task […]
Press releases July 23, 2026
IMC welcomes premiers’ call for sustainable healthcare funding
Ottawa, July 23, 2026 – Innovative Medicines Canada (IMC) welcomes today’s call from Canada’s Premiers, issued at the Council of […]
In the news July 21, 2026
Opinion: It’s faster to fly a human around the moon than to get a new drug to Canadians
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
In the news June 25, 2026
Canada’s wait for new medicines is long — and about to get longer
By Dr. Bettina Hamelin Article originally published on healthinsight.ca, June 25, 2026. Global drug policy changes are making it increasingly difficult […]
In the news June 11, 2026
Canada’s innovation gap: why your access to medicines is at risk
By Dr. Bettina Hamelin Article originally published on the Toronto Star, June 11, 2026. There’s a quiet crisis unfolding behind closed […]
In the news June 09, 2026
The case for fixing Canada’s innovation gap
The global rules governing how innovative medicines are valued and priced are being rewritten— and Canada must be ready. By […]
In the news April 28, 2026
A critical moment for Canada: Ensuring world-leading access to innovative medicines
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
In the news April 22, 2026
The task force that could get things right for Canadian patients
Article by Bettina Hamelin originally published in the Hill Times Health Policy Briefing, page 21, April 22, 2026. By Dr. […]
In the news April 10, 2026
Interview with Bettina Hamelin in Investment Reports
As originally published in Investment Reports, featured by Newsweek on 10th April 2026 Over the past year, have you seen […]
In the news March 24, 2026
Your access to medicines is at risk
As originally published by Bettina Hamelin on LinkedIn on 24 March 2026 By Bettina Hamelin Recent global drug policy changes […]
